ABL1 and ABL2 promote medulloblastoma leptomeningeal dissemination is a research paper published in Neuro-Oncology Advances (2023). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R03 NS114629-01
National Institutes of Health
Grant: P50 CA190991
National Institutes of Health
Grant: P30 CA014236
National Institutes of Health
Grant: 1R01CA246133
NCI NIH HHS
Grant: R01 CA246133
NIGMS NIH HHS
Grant: T32 GM007753
NIGMS NIH HHS
Grant: T32 GM144273
NCI NIH HHS
Grant: K08 CA256045
National Institutes of Health
Grant: 5P30CA014236-30
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
National Institutes of Health
Grant: 5K08CA256045-03
Enhancing the efficacy of Radiation Therapy for brainstem glioma by targeting ATM
National Institutes of Health
Grant: 5P50CA190991-05
Duke SPORE in Brain Cancer
National Institutes of Health
Grant: 5R01CA246133-05
Targeting tumor-neural cell interactions to inhibit lung cancer brain metastasis
National Institutes of Health
Grant: 5R03NS114629-02
Unraveling the Role of ABL 1 and 2 as Drivers of Medulloblastoma Leptomeningeal Metastases
FWCI
2.00
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals